Skip to main navigation Skip to search Skip to main content

Response gene to complement 32 expression in macrophages augments paracrine stimulation-mediated colon cancer progression

  • Peng Zhao
  • , Bing Wang
  • , Zhen Zhang
  • , Wei Zhang
  • , Yan Liu
  • Qingdao University
  • The 971 Hospital of People’s Liberation Army Navy

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

M2-polarized tumor associated macrophages (TAMs) play an important role in tumor progression. It has been reported that response gene to complement 32 (RGC-32) promotes M2 macrophage polarization. However, whether RGC-32 expression in macrophages could play a potential role in tumor progression remain unclear. Here we identified that increasing RGC-32 expression in colon cancer and tumor associated macrophages was positively correlated with cancer progression. In vitro studies confirmed that colon cancer cells upregulated RGC-32 expression of macrophages via secreting TGF-β1. RGC-32 expression promoted macrophage migration. In addition, stimulation of HCT-116 cells with the condition mediums of RGC-32-silienced or over-expressed macrophages affected tumor cell colony formation and migration via altered COX-2 expression. In an animal model, macrophages with RGC-32 knockdown significantly decreased the expression of COX-2 and Ki67 in the xenografts, and partly inhibited tumor growth. Together, our results provide the evidences for a critical role of TGF-β1/RGC-32 pathway in TAMs and colon cancer cells during tumor progression.

Original languageEnglish
Article number776
JournalCell Death and Disease
Volume10
Issue number10
DOIs
StatePublished - 1 Oct 2019
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Response gene to complement 32 expression in macrophages augments paracrine stimulation-mediated colon cancer progression'. Together they form a unique fingerprint.

Cite this